ACR Convergence 2020

November 5-9, 2020. All Virtual.

View by Number View by Title View Sessions

View by Date

Abstract Number: 0008

COVID-19 Infection Among Patients with Rheumatic Disease on Biologic & Targeted Therapies: A Systematic Review
Abstract Number: 0009

Prevalence of Hydroxychloroquine and Chloroquine Side Effects in Rheumatology Patients: A Retrospective Survey of 115 Cases
Abstract Number: 0010

Antirheumatic Disease Therapies in Patients with COVID-19: A Systematic Review and Meta-analysis
Abstract Number: 0011

Patients Receiving Cytokine Inhibitors Have Low Prevalence of SARS-CoV-2 Infection
Abstract Number: 0012

Experiences of Patients with Rheumatic Diseases in the US During the Early Months of the COVID-19 Pandemic
Abstract Number: 0013

Colchicine to Weather the Storm in Hospitalized Patients with COVID-19
Abstract Number: 0014

Does the Type of Rheumatic Disease or Biologic Treatment Increase the Risk of Developing Severe COVID-19?
Abstract Number: 0015

COVID -19 Lung Inflammation – What Have We Learnt so Far ?
Abstract Number: 0016

Differential Characteristics in Inflammatory Rheumatologic Patients with Severe and Mild COVID-19 Infection
Abstract Number: 0017

Impact of COVID19 on Missed/Cancelled Rheumatology Office Visits and Parenteral Immunosuppressive Medications
Abstract Number: 0018

PROMIS-29 and Health Related Quality of Life in Rheumatology Outpatients During the COVID-19 Pandemic in New York City
Abstract Number: 0019

Lasting COVID-19 Impacts on US Rheumatology Practices
Abstract Number: 0020

Characteristics of Rheumatology Outpatients with Suspected or Confirmed COVID-19 During the Pandemic in New York City
Abstract Number: 0021

Prioritizing Patient Safety While Maintaining Study Integrity During COVID-19: Lupus Intervention Fatigue Trial Modifications and Lessons Learned
Abstract Number: 0022

Association Between Changes in Pain Sensitization and Changes in Disease Activity After 12 Weeks of Disease Modifying Anti-Rheumatic Drug Therapy in Rheumatoid Arthritis